Matrine Inhibits the Activity of Translation Factor eIF4E through Dephosphorylation of 4E-BP1 in Gastric MKN45 Cells

Abstract

Matrine, from Sophora flavescens, could remarkably inhibit tumor growth and induce apoptosis in various cancer cells in vitro. eIF4E and its inhibitor 4E-BP1 play key roles in regulating mRNA translation and cell proliferation. However, it remained elusive whether matrine inhibited cancer cells growth through attenuating the activity of 4E-BP1. In this study, we analyzed the effects of matrine on 4E-BP1 and eIF4E in gastric cancer MKN45 cells. Immunoblots showed that matrine inhibited the activity of eIF4E through dephosphorylation of 4E-BP1 in a dose- and time-dependent manner. We found that matrine inactivated Erk1/2, an upstream regulator of 4E-BP1 and eIF4E, and remarkably reduced the phosphorylation level of 4E-BP1 and eIF4E, whereas 4E-BP1 was little influenced by JNK, p38 or Akt/mTOR. Inactivation of PP2A obviously decreased the phosphorylation of 4E-BP1 in matrine-treated cells. These findings suggested that matrine inhibits the activity of eIF4E by dephosphorylating 4E-BP1, which partly counts for the growth inhibition in gastric MKN45 cells.

Abbreviations

4E-BP:4E-binding protein

DMSO:dimethyl sulfoxide

EDTA:ethylenediaminetetraacetic acid

eIF:eukaryotic initiation factor

Erk1/2:extracellular-signal regulated kinase 1/2

GAPDH:glyceraldehyde-3-phosphate dehydrogenase

JNK:Jun-N-terminal kinase

MAPK:mitogen-activated protein kinase

mTOR:mammalian target of rapamycin

MTT:3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide

PBS:phosphate-buffered saline

TBS/T:Tris buffer saline/Tween-20

PMSF:phenylmethylsulfonyl fluoride

PP2A:protein phosphatase 2A

TRAIL:tumor necrosis factor α-related apoptosis inducing ligand

Key words

Sophora flavescens - Leguminosae - matrine - eukaryotic initiation factor 4E - 4E-binding protein 1

References

• 1 Cheng H, Xia B, Zhang L, Zhou F, Zhang Y X, Ye M. et al . Matrine improves 2,4,6-trinitrobenzenesulfonic acid-induced colitis in mice.  Pharmacol Res. 2006;  53 202-8.
• 2 Hu M J, Zeng H, Wu Y L, Zhang Y P, Zhang S, Qiao M M. et al . Synergistic effects of matrine and 5-fluorouracil on tumor growth of the implanted gastric cancer in nude mice.  Chin J Dig Dis. 2005;  6 68-71.
• 3 Zhang L P, Jiang J K, Tam J W, Zhang Y, Liu X S, Xu X R. et al . Effects of matrine on proliferation and differentiation in K-562 cells.  Leuk Res. 2001;  25 793-800.
• 4 Liu X S, Jiang J, Jiao X Y, Wu Y E, Lin J H. Matrine-induced apoptosis in leukemia U937 cells: involvement of caspases activation and MAPK-independent pathways.  Planta Med. 2006;  72 501-6.
• 5 Luo C, Zhu Y, Jiang T, Lu X, Zhang W, Jing Q. et al . Matrine induced gastric cancer MKN45 cells apoptosis via increasing pro-apoptotic molecules of Bcl-2 family.  Toxicology. 2007;  229 245-52.
• 6 Richter J D, Sonenberg N. Regulation of cap-dependent translation by eIF4E inhibitory proteins.  Nature. 2005;  433 477-80.
• 7 Constantinou C, Clemens M J. Regulation of the phosphorylation and integrity of protein synthesis initiation factor eIF4GI and the translational repressor 4E-BP1 by p53.  Oncogene. 2005;  24 4839-50.
• 8 Lazaris-Karatzas A, Montine K S, Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap.  Nature. 1990;  345 544-7.
• 9 Miskimins W K, Wang G, Hawkinson M, Miskimins R. Control of cyclin-dependent kinase inhibitor p27 expression by cap-independent translation.  Mol Cell Biol. 2001;  21 4960-7.
• 10 Li S, Perlman D M, Peterson M S, Burrichter D, Avdulov S, Polunovsky V A. et al . Translation initiation factor 4E blocks endoplasmic reticulum-mediated apoptosis.  J Biol Chem. 2004;  279 21 312-7.
• 11 De Benedetti A, Graff J R. eIF-4E expression and its role in malignancies and metastases.  Oncogene. 2004;  23 3189-99.
• 12 Tee A R, Manning B D, Roux P P, Cantley L C, Blenis J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.  Curr Biol. 2003;  13 1259-68.
• 13 Lin T A, Kong X, Haystead T A, Pause A, Belsham G, Sonenberg N. et al . PHAS-I as a link between mitogen-activated protein kinase and translation initiation.  Science. 1994;  266 653-6.
• 14 Wehbe H, Henson R, Lang M, Meng F, Patel T. Pifithrin-{alpha} enhances chemosensitivity by a p38 mitogen-activated protein kinase-dependent modulation of the eukaryotic initiation factor 4E in malignant cholangiocytes.  J Pharmacol Exp Ther. 2006;  319 1153-61.
• 15 Marcotrigiano J, Gingras A C, Sonenberg N, Burley S K. Cocrystal structure of the messenger RNA 5′ cap-binding protein (eIF4E) bound to 7-methyl-GDP.  Cell. 1997;  89 951-61.
• 16 Haghighat A, Mader S, Pause A, Sonenberg N. Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E.  EMBO J. 1995;  14 5701-9.
• 17 Zhu Y, Wang C, Huang J, Ge Z, Dong Q, Zhong X. et al . The Helicobacter pylori virulence factor CagA promotes Erk1/2-mediated Bad phosphorylation in lymphocytes: a mechanism of CagA-inhibited lymphocyte apoptosis.  Cell Microbiol. 2007;  9 952-61.
• 18 Mothe-Satney I, Brunn G J, McMahon L P, Capaldo C T, Abraham R T, Lawrence JC J r. Mammalian target of rapamycin-dependent phosphorylation of PHAS-I in four (S/T)P sites detected by phospho-specific antibodies.  J Biol Chem. 2000;  275 33 836-43.
• 19 Wehbe H, Henson R, Lang M, Meng F, Patel T. Pifithrin-{alpha} enhances chemosensitivity by a p38 mitogen-activated protein kinase-dependent modulation of the eukaryotic initiation factor 4E in malignant cholangiocytes.  J Pharmacol Exp Ther. 2006;  319 1153-61.
• 20 Tee A R, Proud C G. DNA-damaging agents cause inactivation of translational regulators linked to mTOR signalling.  Oncogene. 2000;  19 3021-31.
• 21 Tee A R, Proud C G. Staurosporine inhibits phosphorylation of translational regulators linked to mTOR.  Cell Death Differ. 2001;  8 841-9.
• 22 Horton L E, Bushell M, Barth-Baus D, Tilleray V J, Clemens M J, Hensold J O. p53 activation results in rapid dephosphorylation of the eIF4E-binding protein 4E-BP1, inhibition of ribosomal protein S6 kinase and inhibition of translation initiation.  Oncogene. 2002;  21 5325-34.
• 23 Jeffrey I W, Elia A, Bornes S, Tilleray V J, Gengatharan K, Clemens M J. Interferon-alpha induces sensitization of cells to inhibition of protein synthesis by tumour necrosis factor-related apoptosis-inducing ligand.  FEBS J. 2006;  273 3698-708.
• 24 Minich W B, Balasta M L, Goss D J, Rhoads R E. Chromatographic resolution of in vivo phosphorylated and nonphosphorylated eukaryotic translation initiation factor eIF-4E: increased cap affinity of the phosphorylated form.  Proc Natl Acad Sci USA. 1994;  91 7668-72.
• 25 Scheper G C, van Kollenburg B, Hu J, Luo Y, Goss D J, Proud C G. Phosphorylation of eukaryotic initiation factor 4E markedly reduces its affinity for capped mRNA.  J Biol Chem. 2002;  277 3303-9.
• 26 Knauf U, Tschopp C, Gram H. Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2.  Mol Cell Biol. 2001;  21 5500-11.
• 27 Waskiewicz A J, Flynn A, Proud C G, Cooper J A. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2.  EMBO J. 1997;  16 1909-20.
• 28 Nanahoshi M, Nishiuma T, Tsujishita Y, Hara K, Inui S, Sakaguchi N. et al . Regulation of protein phosphatase 2A catalytic activity by alpha4 protein and its yeast homolog Tap42.  Biochem Biophys Res Commun. 1998;  251 520-6.
• 29 Peterson R T, Desai B N, Hardwick J S, Schreiber S L. Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein.  Proc Natl Acad Sci USA. 1999;  96 4438-42.